Movatterモバイル変換

[0]ホーム
URL:

NO2014010I2 - - Google Patents

Info

Publication number
NO2014010I2
NO2014010I2NO2014010CNO2014010CNO2014010I2NO 2014010 I2NO2014010 I2NO 2014010I2NO 2014010 CNO2014010 CNO 2014010CNO 2014010 CNO2014010 CNO 2014010CNO 2014010 I2NO2014010 I2NO 2014010I2
Authority
NO
Norway
Prior art keywords
treatment
tumors
bone
radium
bones
Prior art date
Application number
NO2014010C
Other languages
Norwegian (no)
Other versions
NO2014010I1 (en
Original Assignee
Algeta Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Algeta AsafiledCriticalAlgeta Asa
Publication of NO2014010I2publicationCriticalpatent/NO2014010I2/no
Publication of NO2014010I1publicationCriticalpatent/NO2014010I1/en

Links

Classifications

Landscapes

Abstract

Processes for the preparation, prepared solutions, and the use of radium-223 for the treatment of calcified tumors, bone tumors, treatment of bones, bone surfaces and soft tissues is described.
NO2014010C1999-01-042014-05-09 Radium 223 salt such as Radium 223 dichlorideNO2014010I1 (en)

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
NO990001ANO310544B1 (en)1999-01-041999-01-04 Preparation and use of radium-223 for the preparation of preparations and kits for the treatment of calcified tissue for palliation, bone cancer therapy and / or bone surface treatment

Publications (2)

Publication NumberPublication Date
NO2014010I2true NO2014010I2 (en)2014-05-09
NO2014010I1 NO2014010I1 (en)2014-06-02

Family

ID=19902803

Family Applications (2)

Application NumberTitlePriority DateFiling Date
NO990001ANO310544B1 (en)1999-01-041999-01-04 Preparation and use of radium-223 for the preparation of preparations and kits for the treatment of calcified tissue for palliation, bone cancer therapy and / or bone surface treatment
NO2014010CNO2014010I1 (en)1999-01-042014-05-09 Radium 223 salt such as Radium 223 dichloride

Family Applications Before (1)

Application NumberTitlePriority DateFiling Date
NO990001ANO310544B1 (en)1999-01-041999-01-04 Preparation and use of radium-223 for the preparation of preparations and kits for the treatment of calcified tissue for palliation, bone cancer therapy and / or bone surface treatment

Country Status (24)

CountryLink
US (2)US6635234B1 (en)
EP (1)EP1140212B1 (en)
JP (2)JP4649044B2 (en)
KR (1)KR100671387B1 (en)
CN (2)CN1194764C (en)
AT (1)ATE331534T1 (en)
AU (1)AU774991B2 (en)
BE (1)BE2014C028I2 (en)
BR (1)BR9916768A (en)
CA (1)CA2358498C (en)
CY (2)CY1105634T1 (en)
DE (1)DE69932183T2 (en)
DK (1)DK1140212T3 (en)
EA (1)EA003496B1 (en)
ES (1)ES2268888T3 (en)
IL (1)IL144135A0 (en)
LU (1)LU92425I2 (en)
MX (1)MXPA01006823A (en)
NO (2)NO310544B1 (en)
NZ (3)NZ545023A (en)
PT (1)PT1140212E (en)
TR (3)TR200201442T2 (en)
WO (1)WO2000040275A2 (en)
ZA (1)ZA200105431B (en)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
NO310544B1 (en)*1999-01-042001-07-23Algeta As Preparation and use of radium-223 for the preparation of preparations and kits for the treatment of calcified tissue for palliation, bone cancer therapy and / or bone surface treatment
NO314537B1 (en)*1999-12-062003-04-07Anticancer Therapeutic Inv Sa Receptor binding conjugates
NO313180B1 (en)*2000-07-042002-08-26Anticancer Therapeutic Inv Sa Visiting alpha particles emitting radiopharmaceuticals
AUPQ923100A0 (en)*2000-08-072000-08-31Peplin Research Pty LtdTreatment of prostate cancer
WO2003061566A2 (en)*2002-01-242003-07-31Yissum Research Development Company Of The Hebrew University Of JerusalemAnti-cancer combination and use thereof
GB0213261D0 (en)*2002-06-102002-07-17Anticancer Therapeutic Inv SaMethod
GB0308731D0 (en)*2003-04-152003-05-21Anticancer Therapeutic Inv SaMethod of radiotherapy
DE602004009184T2 (en)*2003-04-302008-07-03Ramot At Tel Aviv University Ltd. METHOD AND DEVICE FOR RADIOTHERAPY
PL1735013T3 (en)*2004-02-202012-07-31Algeta AsaAlpha- and beta-emitting hydroxyapatite particles
DE102004022200B4 (en)*2004-05-052006-07-20Actinium Pharmaceuticals, Inc. Radium target and process for its preparation
US7914766B1 (en)*2004-06-032011-03-29Ut-Battelle LlcInorganic resins for clinical use of 213Bi generators
GB0423565D0 (en)*2004-10-222004-11-24Algeta AsFormulation
PT2510952T (en)*2005-07-262018-12-18Alpha Tau Medical LtdA radioactive surface source and a method for producing the same
US8709380B1 (en)*2006-02-072014-04-29Sirius Medicine, LlcTargeting agents for enhancing radiation therapy
DE102006008023B4 (en)*2006-02-212008-05-29Actinium Pharmaceuticals, Inc. Method of cleaning 225Ac from irradiated 226Ra targets
JP5197603B2 (en)*2006-09-082013-05-15アクチニウム ファーマシューティカルズ，インコーポレイティド Methods for purifying radium from various sources
EP2116539A1 (en)2008-04-252009-11-11Laboratorios Del. Dr. Esteve, S.A.1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
EP2353598A1 (en)2010-02-042011-08-10Laboratorios Del. Dr. Esteve, S.A.Sigma ligands for use in the prevention and/or treatment of postoperative pain
EP2353591A1 (en)2010-02-042011-08-10Laboratorios Del. Dr. Esteve, S.A.Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
GB201002508D0 (en)2010-02-122010-03-31Algeta AsProduct
GB201007354D0 (en)*2010-04-302010-06-16Algeta AsaMethod
GB201007353D0 (en)*2010-04-302010-06-16Algeta AsaMethod
EP2388005A1 (en)2010-05-212011-11-23Laboratorios Del. Dr. Esteve, S.A.Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
EP2415471A1 (en)2010-08-032012-02-08Laboratorios Del. Dr. Esteve, S.A.Use of sigma ligands in opioid-induced hyperalgesia
EP2524694A1 (en)2011-05-192012-11-21Laboratorios Del. Dr. Esteve, S.A.Use of sigma ligands in diabetes type-2 associated pain
CA2895356A1 (en)2012-12-192014-06-26Bayer Pharma AktiengesellschaftCombination comprising radium-223 for the treatment of cancer
GB201314718D0 (en)*2013-08-162013-10-02Algeta AsQuantification method
EP3077003A1 (en)2013-12-032016-10-12Bayer Pharma AktiengesellschaftCombination of pi3k-inhibitors
CN105934256B (en)2013-12-032019-12-27拜耳制药股份公司PI3K inhibitor combination
CA2933511A1 (en)2013-12-172015-06-25Laboratorios Del Dr. Esteve, S.A.Serotonin-norepinephrine reuptake inhibitors (snris) and sigma receptor ligands combinations
WO2016083739A1 (en)2014-11-262016-06-02Rhodia OperationsComposition comprising lanthanum and actinium-227
GB201600154D0 (en)*2016-01-052016-02-17Bayer AsIsotope preparation method
GB201600153D0 (en)*2016-01-052016-02-17Bayer AsIsotope preparation method
CZ2016821A3 (en)*2016-12-222018-07-04České vysoké učení technické v PrazeA combination for radionuclide therapy for the use as a medicine
AR110995A1 (en)2017-02-242019-05-22Bayer Ag COMBINATION OF QUINASA ATR INHIBITORS WITH RADIO SALT-223
US11529432B2 (en)2017-05-112022-12-20Alpha Tau Medical Ltd.Polymer coatings for brachytherapy devices
RU2020130217A (en)2018-04-022022-05-04Альфа Тау Медикал Лтд. CONTROLLED RELEASE OF RADIONUCLIDES
EP3563875A1 (en)*2018-05-042019-11-06Ceské vysoké ucení technické v PrazeRadium for radionuclide therapy, in combination with calcium metabolism affecting treatment
LU100900B1 (en)*2018-08-102020-02-17Thomas Melchior Homann COMPOUNDS FOR MODULATING A-KETOGLUTARIC ACID (2KG) -DEPENDENT OXYGENASES
FR3086186B1 (en)*2018-09-262022-01-28Orano Med METHOD FOR THE PRODUCTION OF LEAD-212 FROM AN AQUEOUS SOLUTION COMPRISING THORIUM-228 AND ITS DESCENDANTS
FR3088769B1 (en)*2018-11-152020-12-25Orano Med PROCESS FOR PREPARING AT LEAST ONE GENERATOR WITH HIGH RADIUM-228 CONTENT
WO2020180756A1 (en)*2019-03-012020-09-10Washington UniversityCompositions and methods for radiotherapy using chelated radiotherapeutic agents and non-target tissue blockade
IL293575A (en)2019-12-052022-08-01Sciencons AS Production of 212 lead in a high degree of purity
RU2752845C1 (en)*2020-05-132021-08-11Акционерное Общество "Наука И Инновации"Method for obtaining high-purity radium-223
AU2021400142B2 (en)2020-12-162024-11-21Alpha Tau Medical Ltd.Diffusing alpha-emitters radiation therapy with enhanced beta treatment
CN113066598B (en)*2021-03-252023-08-08中国科学院近代物理研究所Irradiation from high-energy proton beam 232 Separation and purification in spallation reaction caused by Th target 223 Method for Ra
US12064643B2 (en)2021-06-102024-08-20Alpha Tau Medical Ltd.Diffusing alpha-emitter radiation therapy for breast cancer
US11964168B2 (en)2021-06-102024-04-23Alpha Tau Medical Ltd.Diffusing alpha-emitter radiation therapy for prostate cancer
US12070621B2 (en)2021-06-102024-08-27Alpha Tau Medical Ltd.Diffusing alpha-emitter radiation therapy for pancreatic cancer
US12076582B2 (en)2021-06-102024-09-03Alpha Tau Medical Ltd.Diffusing alpha-emitter radiation therapy for colorectal cancer
US12076583B2 (en)2021-06-102024-09-03Alpha Tau Medical Ltd.Diffusing alpha-emitter radiation therapy for melanoma
US12076581B2 (en)2021-06-102024-09-03Alpha Tau Medical Ltd.Diffusing alpha-emitter radiation therapy for glioblastoma
US12042668B2 (en)2021-06-102024-07-23Alpha Tau Medical Ltd.Diffusing alpha-emitter radiation therapy for squamous cell carcinoma
US12070620B2 (en)2021-06-102024-08-27Alpha Tau Medical Ltd.Activity levels for diffusing alpha-emitter radiation therapy
AU2023221939A1 (en)2022-02-212024-08-22Bayer Healthcare LlcSystem, method and device for delivery of a therapeutic or diagnostic agent
JP2025507615A (en)2022-02-212025-03-21バイエル・ヘルスケア・エルエルシー Systems, methods and devices for the delivery of therapeutic or diagnostic agents - Patents.com
CN115869658B (en)*2022-12-292025-01-28中国核动力研究设计院 Separation system for preparing Ra-223, separation method, application and preparation method thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CH668489A5 (en)*1982-01-221988-12-30Vnii Mineralnogo Syrya RADIOMETRIC METHOD FOR DETERMINING THE CONCENTRATION OF NATURAL RADIUM ISOTOPES AND DEVICE FOR IMPLEMENTING THE METHOD.
JPH04501265A (en)*1988-10-141992-03-05マリンクロッド・インコーポレイテッド Radiolabeled particulate composition
US4970062A (en)*1989-05-301990-11-13The United States Of America As Represented By The United States Department Of EnergyColloid labelled with radionuclide and method
EP0614377A1 (en)*1991-11-141994-09-14Battelle Memorial InstituteMethod for diagnosing and treating cancer
EP0700304A4 (en)*1993-05-171999-01-07Immunomedics IncImproved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
US5809394A (en)*1996-12-131998-09-15Battelle Memorial InstituteMethods of separating short half-life radionuclides from a mixture of radionuclides
US6117413A (en)*1997-11-122000-09-12Battelle Memorial InstituteRadionuclide-binding compound, a radionuclide delivery system, a method of making a radium complexing compound, a method of extracting a radionuclide, and a method of delivering a radionuclide
NO310544B1 (en)*1999-01-042001-07-23Algeta As Preparation and use of radium-223 for the preparation of preparations and kits for the treatment of calcified tissue for palliation, bone cancer therapy and / or bone surface treatment
NO314537B1 (en)*1999-12-062003-04-07Anticancer Therapeutic Inv Sa Receptor binding conjugates
NO312708B1 (en)*2000-02-212002-06-24Anticancer Therapeutic Inv Sa Radioactive liposomes for therapy
NO313180B1 (en)*2000-07-042002-08-26Anticancer Therapeutic Inv Sa Visiting alpha particles emitting radiopharmaceuticals
GB0213261D0 (en)*2002-06-102002-07-17Anticancer Therapeutic Inv SaMethod
GB0308731D0 (en)*2003-04-152003-05-21Anticancer Therapeutic Inv SaMethod of radiotherapy
US20060228297A1 (en)*2003-04-152006-10-12Roy LarsenThorium-227 for use in radiotherapy of soft tissue disease

Also Published As

Publication numberPublication date
CN1767078B (en)2012-01-11
JP2010168397A (en)2010-08-05
IL144135A0 (en)2002-05-23
CY2014020I1 (en)2015-12-09
TR200102707T2 (en)2002-03-21
KR20010092772A (en)2001-10-26
DE69932183D1 (en)2006-08-10
EP1140212A2 (en)2001-10-10
AU774991B2 (en)2004-07-15
EA003496B1 (en)2003-06-26
CY1105634T1 (en)2010-12-22
CN1767078A (en)2006-05-03
TR200201440T2 (en)2002-08-21
JP4649044B2 (en)2011-03-09
CN1335779A (en)2002-02-13
NZ534618A (en)2006-03-31
BR9916768A (en)2001-12-04
US6635234B1 (en)2003-10-21
WO2000040275A3 (en)2001-06-21
JP2002534399A (en)2002-10-15
LU92425I2 (en)2014-06-10
BE2014C028I2 (en)2019-03-05
EP1140212B1 (en)2006-06-28
EA200100642A1 (en)2002-02-28
TR200201442T2 (en)2002-08-21
WO2000040275A2 (en)2000-07-13
PT1140212E (en)2006-11-30
ATE331534T1 (en)2006-07-15
AU1700400A (en)2000-07-24
NO990001L (en)2000-07-05
DK1140212T3 (en)2006-10-09
DE69932183T2 (en)2007-05-16
NZ545023A (en)2007-08-31
NO990001D0 (en)1999-01-04
CY2014020I2 (en)2015-12-09
NO310544B1 (en)2001-07-23
US20030206857A1 (en)2003-11-06
JP5433490B2 (en)2014-03-05
NZ513135A (en)2004-09-24
ES2268888T3 (en)2007-03-16
MXPA01006823A (en)2003-07-14
CN1194764C (en)2005-03-30
KR100671387B1 (en)2007-01-19
ZA200105431B (en)2002-07-02
HK1090750A1 (en)2006-12-29
NO2014010I1 (en)2014-06-02
CA2358498A1 (en)2000-07-13
CA2358498C (en)2008-09-16

Similar Documents

PublicationPublication DateTitle
NO2014010I2 (en)
MY155913A (en)Chimeric anti-cd20 antibody treatment of patients receiving bmt or pbsc transpants
MXPA03006771A (en)Modified antibodies and methods of use.
WO2002041837A3 (en)Treatment of mucositis
MY164077A (en)Compositions and uses of et743 for treating cancer
AU5845099A (en)Use of (pex) in the treatment of metabolic bone diseases
AU2000274383A1 (en)Preparation for treating diseases of bone tissues
EP1162956B8 (en)Compositions and methods for improving integrity of compromised body passageways and cavities
AU1233701A (en)Methods and compositions for treating atheroma, tumors and other neoplastic tissue
AU2001234831A1 (en)Magnetoliposome composition for targeted treatment of biological tissue and associated methods
AU1907001A (en)Instrument (osteotome) for forming holes in bone tissue, preferably in jaw-bone tissue
UA32302A (en)Method for preventing postoperative deformities of soft tissues
MD1268B2 (en)Method for surgical treatment of meta-physar fracture of children should bone distal part
AU5760596A (en)Component b as cicatrizant
UA32173A (en)Methods for treating underdeveloped middle area of facial skeleton
UA33331A (en)Method for prophylactics of purulo-septic complications at after-operation period
UA32315A (en)Technique for skin suturing
UA32153A (en)Technique for generating graft for pull-through proctectomy
IT1317076B1 (en)Anti-inflammatory, non-steroid preparation useful for treating osteoarticular afflictions and soft tissue
UA40998A (en)Method for shin amputation
AU2002217680A1 (en)Surface modification of implants for healing in bone and soft tissue
SI1196159T1 (en)Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues
UA32174A (en)Method for surgical treatment of supraorbital hemiangioma
AU2001240529A1 (en)Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
AU5150798A (en)Treatment of bone fracture

Legal Events

DateCodeTitleDescription
MK1KPatent expired
CHADChange of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name:BAYER AS, NO

CHADChange of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name:ALGETA ASA, NO
[8]ページ先頭
©2009-2025 Movatter.jp